# A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses

> **NCT00001108** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 6 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Ritonavir
- **DRUG:** Nelfinavir mesylate
- **DRUG:** Saquinavir
- **DRUG:** Nevirapine
- **DRUG:** Lamivudine
- **DRUG:** Stavudine
- **DRUG:** Didanosine

## Key facts

- **NCT ID:** NCT00001108
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2000-06
- **Target enrollment:** 6 (—)
- **Last updated:** 2021-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001108, "A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00001108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*